Silver Book

Silver Book Fact

Catheter ablation reduces risk of stroke and death among AFib patients

Atrial fibrillation patients who underwent catheter ablation had a reduced risk of stroke and death—2.2% of those who had ablation experienced stroke versus 4.7% on medications alone, and 6% died from stroke versus 23.5% of those on medications alone.

Day J, Crandall B, Osborn J, Weiss J, et al. Atrial Fibrillation Ablation Significantly Reduces Long-Term Mortality and Strokes in a Large Patient Population; 2010. https://www.heartrhythmjournal.com/issue/S1547-5271(10)X0004-2

Reference

Title
Atrial Fibrillation Ablation Significantly Reduces Long-Term Mortality and Strokes in a Large Patient Population
Publication
Heart Rhythm 2010: 31st Annual Scientific Sessions of the Heart Rhythm Society
Publication Date
2010
Authors
Day J, Crandall B, Osborn J, Weiss J, et al.
Volume & Issue
Volume 7, Issue 5
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • AFib practice guidelines reduce direct health care costs
    The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  
  • Stroke prevention through optimal anticoagulation
    If half of atrial fibrillation patients who currently receive warfarin in a routine care setting had their anti-coagulation optimized, around 9,000 strokes and more than 29,000 bleeds would be prevented.  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.  
  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…